Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 421-090-1 | CAS number: 131298-44-7 Isodecyl benzoate
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 06/22/1987 - 07/06/1987
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP conducted study following EPA Guideline 81-1 (1982)
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 987
- Report date:
- 1987
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- EPA OPP 81-1 (Acute Oral Toxicity)
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- standard acute method
- Limit test:
- yes
Test material
- Reference substance name:
- -
- EC Number:
- 421-090-1
- EC Name:
- -
- Cas Number:
- 131298-44-7
- Molecular formula:
- C17H26O2
- IUPAC Name:
- undecyl benzoate
- Reference substance name:
- Benzoic acid, C9-11, C10-rich branched alkyl esters
- IUPAC Name:
- Benzoic acid, C9-11, C10-rich branched alkyl esters
- Details on test material:
- clear, colorless liquid; stored at room temperature
Constituent 1
Constituent 2
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- Young adult male and female albino rats of the Sprague-Dawley strain were procured, separated by sex, maintained in group cages in temperature and humidity controlled quarters, provided continuous access to Purina Rodent Chow and water and held for an acclimation period of at least 7 days. Animal husbandry and housing at the lab at which the study was conducted comply with the standards outlined in the "Guide for the Care and Use of Laboratory Animals."
Acclimated animals were chosen at random for the study. Test animals were housed by sex in groups of five and identified by animal number and corresponding ear tag. Food and water were available ad libitum throughout the study, except for an overnight period just before test material administration when food, but not water, was withheld.
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- unchanged (no vehicle)
- Details on oral exposure:
- An individual dose was calculated for each animal based upon its fasted body weight and administered undiluted by gavage.
- Doses:
- The dose volume of the test material was 5.26 mL/kg of body weight based upon an average bulk density of 0.95 g/mL.
- No. of animals per sex per dose:
- 5 males, 5 females
- Control animals:
- no
- Details on study design:
- 5 male and 5 female Sprague-Dawley rats were exposed by oral gavage to the undiluted test material at a level of 5.26mL/kg of body weight based upon an average bulk density of 0.95 g/mL. The animals were observed for clinical signs and mortality at 1, 2.5, 4 hours after test material administration. The animals were observed daily thereafter for 14 days for clinical signs and twice daily for mortality. All animals were weighed just before test material administration, at 7 days and at study termination. At study termination all animals were euthanized, subjected to a gross necropsy examination, and all abnormalities were recorded.
Results and discussion
Effect levels
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 5 mg/kg bw
- Based on:
- test mat.
- Mortality:
- No mortality was see in the test animals.
- Clinical signs:
- other: All test animals were observed as appearing normal at 1.0 and 2.5 hours after dosing. At the 4.0 hour observation time point, 2/5 in both the male and female groups were observed as having diarrhea. Observations made on Days 1 and 2 indicated and all fi
- Gross pathology:
- The five male rats showed no visible lesions. Three of the 5 female rats also showed no visible lesions. The necropsy comments for one female rat indicated Kidney (right) - enlarged pelvis filled with tan granules. The necropsy comments for a second female rat indicated Spleen - opaque capsule over entire surface.
Applicant's summary and conclusion
- Conclusions:
- A 14 day acute oral gavage rat toxicity study was conducted using five male rats and five female rats. The estimated oral LD50 for both males and females is >5.0 g/kg of body weight.
- Executive summary:
Isodecyl benzoate was administered by oral gavage to 5 male and 5 female Sprague Dawley rats at the at the limit dose of 5.0 g/kg bodyweight to assess the acute oral lethality. An individulal dose was calculated for each animal based on its fasted body weight (202 -280 g range) and administered undiluted. The animals were observed for clinical signs at 1, 2.5 and 4 hours after test material administration and daily thereafter for 14 days for clinical signs and twice daily for mortality. Animals were weighed just before test material administration, at 7 days, and at 14 days, study termination. There was no mortality. All animals were euthanized and subjected to a gross necropsy examination and all abnormalities were recorded. The five male rats showed no visible lesions. Three of the 5 female rats also showed no lesions. The necropsy comments for one female indicated right kidney enlarged pelvis filled with tan granules and for the second female, the indication was an opaque capsule over the entire spleen surface. The LD50 was determined to be greater than 5000 mg/kg. This finding does not warrant the classification of isodecyl benzoate under the new Regulation (EC) 1272/2008 on classification, labeling and packaging of substancs and mixtures (CLP) or under the Directive 67/518/EEC for dangerous substances and Directive 1999/45/EC for preparations.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.